SOLENO THERAPEUTICS INC (SLNO)
US8342033094 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -52.02M | -38.99M | -24.07M | -30.91M | -24.64M | |||
| Depreciation Amortization | 1.96M | 1.96M | 1.96M | 1.96M | 1.95M | |||
| Change In Working Capital | 4.76M | 2.93M | -760.00K | -1.15M | 2.98M | |||
| Other non cash items | 14.58M | 9.16M | 2.08M | 2.33M | -5.51M | |||
| OPERATING CASH FLOW | -30.74M | -24.94M | -20.78M | -27.77M | -25.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.00K | 0.00 | -10.00K | -20.00K | -10.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -115.24M | 0.00 | -10.00K | -20.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -10.00K | -20.00K | |||
| Stock Issued/Repurchased | 180.96M | 180.02M | 15.15M | 0.00 | 53.74M | |||
| Other Financing Activity | N/A | 0.00 | -1.06M | -120.00K | N/A | |||
| FINANCING CASH FLOW | 180.96M | 180.02M | 14.09M | -130.00K | 53.72M | |||
| CHANGE IN CASH | 34.98M | 155.08M | -6.70M | -27.92M | 28.49M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.74M | -24.94M | -20.78M | -27.77M | -25.22M | |||
| Capital Expenditure | -11.00K | 0.00 | -10.00K | -20.00K | -10.00K | |||
| FREE CASH FLOW | -30.75M | -24.94M | -20.79M | -27.79M | -25.23M | |||
All data in USD